Brief: Lineage Cell Therapeutics Inc Reports Q3 Loss Per Share Of $0.04

Lineage Cell Therapeutics

10/11/2022 21:14

Nov 10 (Reuters) - Lineage Cell Therapeutics Inc
 LCTX.A :
    * LINEAGE CELL THERAPEUTICS REPORTS THIRD QUARTER 2022
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
    * TOTAL REVENUES FOR THREE MONTHS ENDED SEPTEMBER 30, 2022
WERE
APPROXIMATELY $3.0 MILLION, A NET INCREASE OF $0.7 MILLION
    * Q3 LOSS PER SHARE $0.04
    * Q3 EARNINGS PER SHARE VIEW $-0.04, REVENUE VIEW $3.9
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nBw9lDHMda 
Further company coverage:  LCTX.A 
 ((Reuters.Briefs@thomsonreuters.com;;))